A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients.

Sosman JA, Fisher SG, Kefer C, Fisher RI, Ellis TM
Ann Oncol. 1994 5 (5): 447-52

PMID: 7521206 · DOI:10.1093/oxfordjournals.annonc.a058878

MeSH Terms (20)

Adult Aged Antigens, CD Antigens, Differentiation, T-Lymphocyte CD56 Antigen Drug Administration Schedule Edema Eosinophilia Eosinophils Female Humans Infusions, Intravenous Interleukin-2 Interleukin-4 Killer Cells, Lymphokine-Activated Killer Cells, Natural Leukocyte Count Male Middle Aged Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: